Unknown

Dataset Information

0

Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E. coli FMN riboswitch.


ABSTRACT: Bacterial riboswitches are non-coding RNA structural elements that direct gene expression in numerous metabolic pathways. The key regulatory roles of riboswitches, and the urgent need for new classes of antibiotics to treat multi-drug resistant bacteria, has led to efforts to develop small-molecules that mimic natural riboswitch ligands to inhibit metabolic pathways and bacterial growth. Recently, we reported the results of a phenotypic screen targeting the riboflavin biosynthesis pathway in the Gram-negative bacteria Escherichia coli that led to the identification of ribocil, a small molecule inhibitor of the flavin mononucleotide (FMN) riboswitch controlling expression of this biosynthetic pathway. Although ribocil is structurally distinct from FMN, ribocil functions as a potent and highly selective synthetic mimic of the natural ligand to repress riboswitch-mediated ribB gene expression and inhibit bacterial growth both in vitro and in vivo. Herein, we expand our analysis of ribocil; including mode of binding in the FMN binding pocket of the riboswitch, mechanisms of resistance and structure-activity relationship guided efforts to generate more potent analogs.

SUBMITTER: Howe JA 

PROVIDER: S-EPMC5056776 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E. coli FMN riboswitch.

Howe John A JA   Xiao Li L   Fischmann Thierry O TO   Wang Hao H   Tang Haifeng H   Villafania Artjohn A   Zhang Rumin R   Barbieri Christopher M CM   Roemer Terry T  

RNA biology 20160802 10


Bacterial riboswitches are non-coding RNA structural elements that direct gene expression in numerous metabolic pathways. The key regulatory roles of riboswitches, and the urgent need for new classes of antibiotics to treat multi-drug resistant bacteria, has led to efforts to develop small-molecules that mimic natural riboswitch ligands to inhibit metabolic pathways and bacterial growth. Recently, we reported the results of a phenotypic screen targeting the riboflavin biosynthesis pathway in the  ...[more]

Similar Datasets

| S-EPMC7780486 | biostudies-literature
| S-EPMC6298564 | biostudies-literature
| S-EPMC3201879 | biostudies-literature
| S-EPMC11188086 | biostudies-literature
| S-EPMC2858708 | biostudies-literature
| S-EPMC3600479 | biostudies-literature
| S-EPMC3839739 | biostudies-literature
| S-EPMC1300496 | biostudies-other
| S-EPMC7573352 | biostudies-literature
| S-EPMC2000436 | biostudies-literature